DRUG-TREATMENT OF HYPERTENSION IN PATIENTS WITH DIABETES-MELLITUS

被引:73
作者
STEIN, PP
BLACK, HR
机构
[1] YALE UNIV, SCH MED, CARDIOVASC MED SECT, 333 CEDAR ST, NEW HAVEN, CT 06510 USA
[2] YALE UNIV, SCH MED, ENDOCRINOL SECT, NEW HAVEN, CT 06510 USA
关键词
D O I
10.2337/diacare.14.6.425
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with diabetes mellitus have an increased prevalence of hypertension and its vascular consequences, including coronary and cerebrovascular disease. Drug treatment of hypertension in diabetic subjects is fraught with potential difficulties, including the altered efficacy of medications, the increased risk of side effects, and the possibility of worsening glycemic control and increasing serum lipid levels. Despite these difficulties, treatment is an important part of reducing morbidity and mortality from vascular events. Antihypertensive therapy may also have the potential to prevent or retard the development of diabetic nephropathy. In this article, we discuss the efficacy and metabolic and nonmetabolic side effects of the various classes of antihypertensive agents in patients with diabetes mellitus and suggest a stepped-care approach to the drug treatment of patients with hypertension and diabetes.
引用
收藏
页码:425 / 448
页数:24
相关论文
共 263 条
[1]   NIFEDIPINE AND ENDOCRINE STATUS IN DIABETIC-PATIENTS [J].
ABADIE, E ;
GAUVILLE, C ;
BRISSON, C .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (04) :648-650
[2]  
ABRAMSON EA, 1966, LANCET, V2, P1386
[3]   TREATMENT-INDUCED BLOOD-PRESSURE REDUCTION AND THE RISK OF MYOCARDIAL-INFARCTION [J].
ALDERMAN, MH ;
OOI, WL ;
MADHAVAN, S ;
COHEN, H .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (07) :920-924
[4]   EFFECTS OF PROPRANOLOL ON BLOOD SUGAR, INSULIN AND FREE FATTY ACIDS [J].
ALLISON, SP ;
CHAMBERLAIN, MJ ;
MILLER, JE ;
FERGUSON, R ;
GILLETT, AP ;
BEMAND, BV ;
SAUNDERS, RA .
DIABETOLOGIA, 1969, 5 (05) :339-+
[5]  
AMERY A, 1982, ACTA CARDIOL, V37, P235
[6]  
AMERY A, 1978, LANCET, V1, P681
[7]   NEGATIVE EFFECTS OF DIURETIC DRUGS ON METABOLIC RISK-FACTORS FOR CORONARY HEART-DISEASE - POSSIBLE ALTERNATIVE DRUG THERAPIES [J].
AMES, RP .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (04) :632-638
[8]  
AMES RP, 1976, LANCET, V1, P721
[9]   THE EFFECTS OF ANTIHYPERTENSIVE DRUGS ON SERUM-LIPIDS AND LIPOPROTEINS .2. NON-DIURETIC DRUGS [J].
AMES, RP .
DRUGS, 1986, 32 (04) :335-357
[10]   METABOLIC DISTURBANCES INCREASING THE RISK OF CORONARY HEART-DISEASE DURING DIURETIC-BASED ANTIHYPERTENSIVE THERAPY - LIPID ALTERATIONS AND GLUCOSE-INTOLERANCE [J].
AMES, RP .
AMERICAN HEART JOURNAL, 1983, 106 (05) :1207-1214